Fenwick & West represented Freenome in the transaction.Freenome, a biotechnology company developing blood tests for early cancer detection, announced the addition of $254 million from new…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
